Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Leverage past spending insights to shape your future budget and improve financial forecasting for upcoming months.
21,942 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Could Netflix stock fall? This guide delves into the bear case, valuation pressures, and practical steps investors ca...
The Justice Department announced a multi-state PFAS settlement with Chemours, totaling about $450 million in penaltie...
The Trade Desk surprised with strong earnings, yet its stock fell. This in-depth analysis breaks down the reasons beh...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
Dreaming of a $5,251 monthly Social Security check? This guide unpacks the exact earnings and timing needed, plus pra...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
A tech sell-off can feel overwhelming, but it often creates value for patient buyers. This guide shows how to identif...
Goldman Sachs analysts forecast a 22% jump in S&P 500 Q2 earnings driven by AI and energy gains, complicating retirem...
RZC Investments, the Walton family–funded private equity arm, has paused new investments while it reevaluates its fun...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...